The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) of Arch Venture Fund Ix Overage, L.p. since 2026.
This trader's CIK number is 1666307.
At the time of last reporting, Arch Venture Fund Ix Overage, L.p. was the 10% Owner of Lyell Immunopharma, Inc.. (stock ticker symbol LYEL).
Also see all insider trading activities at Lyell Immunopharma, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2026 | LYEL | 488,090 | $12,499,984 | 0 | $0 | 0 | $0 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2026-03-06 | LYEL | Buy | 488,090 | 25.61 | 12,499,984 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Arch Venture Fund Ix Overage, L.p. (10% Owner of Lyell Immunopharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.